These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 30723918)
1. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma. Tsang FH; Law CT; Tang TC; Cheng CL; Chin DW; Tam WV; Wei L; Wong CC; Ng IO; Wong CM Hepatology; 2019 Jun; 69(6):2502-2517. PubMed ID: 30723918 [TBL] [Abstract][Full Text] [Related]
2. Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors. Call SG; Duren RP; Panigrahi AK; Nguyen L; Freire PR; Grimm SL; Coarfa C; Conneely OM Sci Rep; 2020 Feb; 10(1):2851. PubMed ID: 32071334 [TBL] [Abstract][Full Text] [Related]
3. Co-overexpression of BRD4 and CDK7 promotes cell proliferation and predicts poor prognosis in HCC. Li X; Zheng C; Liu Y; Sun H; Qian Y; Fan H Heliyon; 2024 Jan; 10(2):e24389. PubMed ID: 38293462 [TBL] [Abstract][Full Text] [Related]
4. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma. Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295 [TBL] [Abstract][Full Text] [Related]
5. Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression. Li GQ; Guo WZ; Zhang Y; Seng JJ; Zhang HP; Ma XX; Zhang G; Li J; Yan B; Tang HW; Li SS; Wang LD; Zhang SJ Oncotarget; 2016 Jan; 7(3):2462-74. PubMed ID: 26575167 [TBL] [Abstract][Full Text] [Related]
6. TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network. Chen D; Zou J; Zhao Z; Tang X; Deng Z; Jia J; Liu S Cell Death Dis; 2018 Oct; 9(11):1110. PubMed ID: 30382079 [TBL] [Abstract][Full Text] [Related]
7. Impact of bromodomain-containing protein 4 (BRD4) and intestine-specific homeobox (ISX) expression on the prognosis of patients with hepatocellular carcinoma' for better clarity. Chuang KT; Wang SN; Hsu SH; Wang LT Cancer Med; 2021 Aug; 10(16):5545-5556. PubMed ID: 34173348 [TBL] [Abstract][Full Text] [Related]
8. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma. Cai H; Liang J; Jiang Y; Wang Z; Li H; Wang W; Wang C; Hou J J Exp Clin Cancer Res; 2024 Mar; 43(1):69. PubMed ID: 38443991 [TBL] [Abstract][Full Text] [Related]
9. Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming. Xiong L; Wu F; Wu Q; Xu L; Cheung OK; Kang W; Mok MT; Szeto LLM; Lun CY; Lung RW; Zhang J; Yu KH; Lee SD; Huang G; Wang CM; Liu J; Yu Z; Yu DY; Chou JL; Huang WH; Feng B; Cheung YS; Lai PB; Tan P; Wong N; Chan MW; Huang TH; Yip KY; Cheng AS; To KF Nat Commun; 2019 Jan; 10(1):335. PubMed ID: 30659195 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma. Zhou J; Li W; Guo J; Li G; Chen F; Zhou J Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956 [TBL] [Abstract][Full Text] [Related]
11. BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma. Zhang P; Dong Z; Cai J; Zhang C; Shen Z; Ke A; Gao D; Fan J; Shi G Int J Immunopathol Pharmacol; 2015 Mar; 28(1):36-44. PubMed ID: 25816404 [TBL] [Abstract][Full Text] [Related]
12. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells. Brauckhoff A; Malz M; Tschaharganeh D; Malek N; Weber A; Riener MO; Soll C; Samarin J; Bissinger M; Schmidt J; Longerich T; Ehemann V; Schirmacher P; Breuhahn K J Hepatol; 2011 Nov; 55(5):1049-57. PubMed ID: 21356256 [TBL] [Abstract][Full Text] [Related]
13. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma. Guo Y; Wang J; Zhang L; Shen S; Guo R; Yang Y; Chen W; Wang Y; Chen G; Shuai X Hepatology; 2016 Apr; 63(4):1240-55. PubMed ID: 26680504 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling. Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567 [TBL] [Abstract][Full Text] [Related]
15. SOX2 represses c-MYC transcription by altering the co-activator landscape of the c-MYC super-enhancer and promoter regions. Ormsbee Golden BD; Gonzalez DV; Yochum GS; Coulter DW; Rizzino A J Biol Chem; 2024 Sep; 300(9):107642. PubMed ID: 39122009 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356 [TBL] [Abstract][Full Text] [Related]
17. Heat shock transcription factor 1 facilitates liver cancer progression by driving super-enhancer-mediated transcription of MYCN. Liu Y; Shi Q; Su Y; Chen Z; He X Cancer Med; 2024 Sep; 13(17):e70157. PubMed ID: 39248163 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma. Zhang X; Zhang X; Wang T; Wang L; Tan Z; Wei W; Yan B; Zhao J; Wu K; Yang A; Zhang R; Jia L Cancer Lett; 2018 Jul; 426():98-108. PubMed ID: 29653269 [TBL] [Abstract][Full Text] [Related]
19. ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway. Wu M; Zhou Y; Fei C; Chen T; Yin X; Zhang L; Ren Z Int J Oncol; 2020 Sep; 57(3):845-857. PubMed ID: 32705157 [TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. Kanda M; Sugimoto H; Kodera Y World J Gastroenterol; 2015 Oct; 21(37):10584-97. PubMed ID: 26457018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]